IMAX Stock Analysis: Imax | NYSE
Entertainment | NYSE, USA | Market Cap: 2.892m USD | 12M Return: 90.2% | CA45245E1097 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 66.8M
EPS Trend: 82.7%
Qual. Beats: 1
Rev. Trend: 55.3%
Qual. Beats: 1
Warnings
No concerns identified
Tailwinds
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
IMAX Corporation is a global technology platform for entertainment and events, operating in two segments: Content Solutions and Technology Products and Services. The company generates revenue through a hybrid business model combining content remastering (DMR) and IMAX Enhanced distribution with the sale, lease, and servicing of proprietary large-format theater systems, cameras, and post-production equipment. Its network spans over 70 countries, with customers including commercial cinemas, museums, zoos, theme parks, and home entertainment partners.
Factual context: IMAX sits within the Movies & Entertainment sub-industry (GICS Communication Services), a sector under structural pressure from the post-pandemic shift of viewers toward streaming and on-demand platforms, which is precisely the dynamic behind IMAX Enhanced and its AI-based streaming technology offerings. As a Canadian-founded hardware and content licensor rather than a traditional film studio, the company is asset-light in content ownership but capital-intensive in rolling out new theater systems.
- China box office recovery drives network revenue
- Hollywood tentpole film slate pressures attendance and margins
- New theater system installations lift technology product sales
| Net Income: 40.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.14 > 0.02 and ΔFCF/TA 8.32 > 1.0 |
| NWC/Revenue: 84.40% < 20% (prev 87.59%; Δ -3.19% < -1%) |
| CFO/TA 0.14 > 3% & CFO 132.6m > Net Income 40.9m |
| Net Debt (122.7m) to EBITDA (130.1m): 0.94 < 3 |
| Current Ratio: 2.66 > 1.5 & < 3 |
| Outstanding Shares: last quarter (56.6m) vs 12m ago 2.55% < -2% |
| Gross Margin: 59.14% > 18% (prev 56.46%; Δ 2.68% > 0.5%) |
| Asset Turnover: 46.58% > 50% (prev 41.73%; Δ 4.85% > 0%) |
| Interest Coverage Ratio: 9.56 > 6 (EBIT TTM 71.6m / Interest Expense TTM 7.49m) |
| A: 0.38 (Total Current Assets 562.3m - Total Current Liabilities 211.1m) / Total Assets 917.9m |
| B: -0.25 (Retained Earnings -230.8m / Total Assets 917.9m) |
| C: 0.08 (EBIT TTM 71.6m / Avg Total Assets 893.2m) |
| D: 0.76 (Book Value of Equity 355.9m / Total Liabilities 467.5m) |
| Altman-Z'' = 3.03 = A |
| DSRI: 0.87 (Receivables 330.4m/331.3m, Revenue 416.1m/362.5m) |
| GMI: 0.95 (GM 56.46% / 59.14%) |
| AQI: 0.82 (AQ_t 0.13 / AQ_t-1 0.15) |
| SGI: 1.15 (Revenue 416.1m / 362.5m) |
| TATA: -0.10 (NI 40.9m - CFO 132.6m) / TA 917.9m) |
| Beneish M = -3.19 (Cap -4..+1) = AA |
As of August 27, 2026, the stock is trading at USD 52.76 with a total of 745,831 shares traded. Over the past week, the price has changed by -1.77%, over one month by +16.96%, over three months by +29.92% and over the past year by +90.19%.
Current recommended Stop Loss: 47.50 (which is 10% or 2.6 ATR below the current price).
Imax has received a consensus analysts rating of 4.36. Therefore, it is recommended to buy IMAX.
- StrongBuy: 7
- Buy: 2
- Hold: 1
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 51.2 | -3% |
P/E Trailing = 72.2466
P/E Forward = 34.2466
P/S = 6.9515
P/B = 8.1272
P/EG = 0.8895
Revenue TTM = 416.1m USD
EBIT TTM = 71.6m USD
EBITDA TTM = 130.1m USD
Long Term Debt = 243.8m USD (from longTermDebt, last quarter)
Short Term Debt = 38.8m USD (from shortTermDebt, last quarter)
Debt = 282.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 122.7m USD (calculated: Debt 282.6m - CCE 159.9m)
Enterprise Value = 3.02b USD (2.89b + Debt 282.6m - CCE 159.9m)
Interest Coverage Ratio = 9.56 (Ebit TTM 71.6m / Interest Expense TTM 7.49m)
EV/FCF = 23.86x (Enterprise Value 3.02b / FCF TTM 126.4m)
FCF Yield = 4.19% (FCF TTM 126.4m / Enterprise Value 3.02b)
FCF Margin = 30.38% (FCF TTM 126.4m / Revenue TTM 416.1m)
Net Margin = 9.84% (Net Income TTM 40.9m / Revenue TTM 416.1m)
Gross Margin = 59.14% ((Revenue TTM 416.1m - Cost of Revenue TTM 170.0m) / Revenue TTM)
Gross Margin QoQ = 61.16% (prev 56.29%)
Tobins Q-Ratio = 3.28 (Enterprise Value 3.02b / Total Assets 917.9m)
Interest Expense / Debt = 2.65% (Interest Expense 7.49m / Debt 282.6m)
Taxrate = 24.40% (15.2m / 62.3m)
NOPAT = 54.1m (EBIT 71.6m * (1 - 24.40%))
Current Ratio = 2.66 (Total Current Assets 562.3m / Total Current Liabilities 211.1m)
Debt / Equity = 0.79 (Debt 282.6m / totalStockholderEquity, last quarter 355.9m)
Debt / EBITDA = 0.94 (Net Debt 122.7m / EBITDA 130.1m)
Debt / FCF = 0.97 (Net Debt 122.7m / FCF TTM 126.4m)
Total Stockholder Equity = 344.7m (last 4 quarters mean from totalStockholderEquity)
RoA = 4.58% (Net Income 40.9m / Total Assets 917.9m)
RoE = 11.87% (Net Income TTM 40.9m / Total Stockholder Equity 344.7m)
RoCE = 12.17% (EBIT 71.6m / Capital Employed (Equity 344.7m + L.T.Debt 243.8m))
RoIC = 7.47% (NOPAT 54.1m / Invested Capital 724.8m)
WACC = 6.56% (E(2.89b)/V(3.18b) * Re(7.01%) + D(282.6m)/V(3.18b) * Rd(2.65%) * (1-Tc(0.24)))
Discount Rate = 7.01% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 98.88 | Cagr: 2.59%
[DCF] Terminal Value 77.97% ; FCFF base≈94.8m ; Y1≈108.6m ; Y5≈159.9m
[DCF] Fair Price = 41.64 (EV 2.41b - Net Debt 122.7m = Equity 2.28b / Shares 54.8m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 82.74 | EPS CAGR: 21.96% | SUE: 2.28 | # QB: 1
Revenue Correlation: 55.32 | Revenue CAGR: 3.86% | SUE: 1.31 | # QB: 1
EPS current Quarter (2026-09-30): EPS=0.52 | Chg30d=+1.80% | Revisions=+62% | Analysts=8
EPS current Year (2026-12-31): EPS=1.82 | Chg30d=+8.20% | Revisions=+44% | GrowthEPS=+25.8% | GrowthRev=+8.3%
EPS next Year (2027-12-31): EPS=2.05 | Chg30d=+4.84% | Revisions=+10% | GrowthEPS=+12.2% | GrowthRev=+6.2%
[Analyst] Revisions Ratio: +48% (up=14, down=4)